Page last updated: 2024-10-28

hydroxychloroquine and Anemia, Sickle Cell

hydroxychloroquine has been researched along with Anemia, Sickle Cell in 5 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
De Luna, G1
Habibi, A1
Deux, JF1
Colard, M1
Pham Hung d'Alexandry d'Orengiani, AL1
Schlemmer, F1
Joher, N1
Kassasseya, C1
Pawlotsky, JM1
Ourghanlian, C1
Michel, M1
Mekontso-Dessap, A1
Bartolucci, P1
Hussain, FA1
Njoku, FU1
Saraf, SL1
Molokie, RE1
Gordeuk, VR1
Han, J1
Allison, D1
Campbell-Lee, S1
Crane, J1
Vidanovic, V1
Webb, S1
Fraidenburg, D1
Hussain, F1
Rockhold, L1
Harisdangkul, V1
Greenberg, AE1
Kloser, P1
Deloron, P1
Williams, SB1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Study on the Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases Subject to Chronic Transfusion Support.[NCT04526405]63 participants (Actual)Observational2020-07-14Completed
A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic[NCT04417673]500 participants (Actual)Observational2020-06-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

5 other studies available for hydroxychloroquine and Anemia, Sickle Cell

ArticleYear
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
    American journal of hematology, 2020, Volume: 95, Issue:7

    Topics: Acute Chest Syndrome; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Betacoronavirus; Combi

2020
COVID-19 infection in patients with sickle cell disease.
    British journal of haematology, 2020, Volume: 189, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Betacoronavirus; Blood Transfusion; Coronavirus I

2020
COVID-19 infection in patients with sickle cell disease.
    British journal of haematology, 2020, Volume: 189, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Betacoronavirus; Blood Transfusion; Coronavirus I

2020
COVID-19 infection in patients with sickle cell disease.
    British journal of haematology, 2020, Volume: 189, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Betacoronavirus; Blood Transfusion; Coronavirus I

2020
COVID-19 infection in patients with sickle cell disease.
    British journal of haematology, 2020, Volume: 189, Issue:5

    Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Betacoronavirus; Blood Transfusion; Coronavirus I

2020
Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?
    Journal of clinical apheresis, 2020, Volume: 35, Issue:4

    Topics: Acute Chest Syndrome; Adult; Analgesics; Anemia, Sickle Cell; Antiviral Agents; Azithromycin; Betaco

2020
Rheumatoid arthritis occurring with sickle cell anemia--treatment dilemma.
    Journal of the Mississippi State Medical Association, 1989, Volume: 30, Issue:5

    Topics: Anemia, Sickle Cell; Arthritis, Rheumatoid; Female; Humans; Hydroxychloroquine; Lung Diseases; Middl

1989
Assessment of possible drug-resistant Plasmodium falciparum in a pregnant traveller with sickle cell disease.
    Lancet (London, England), 1987, Feb-21, Volume: 1, Issue:8530

    Topics: Adult; Anemia, Sickle Cell; Drug Resistance, Microbial; Female; Humans; Hydroxychloroquine; Infant,

1987